Reciprocal interactions between the amygdala and ventrolateral periaqueductal gray in mediating of Q/N1-17-induced analgesia in the rat

Brain Research

Volumn 980, Issue 1, 2003, Pages 57-70

  Shane, Randi ^a   Acosta, Jazmin ^a   Rossi, Grace C ^b   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

Author keywords

Amygdala; Analgesia; Delta receptor; Kappa receptor; Mu receptor; ORL 1 KOR 3 receptor; Orphanin FQ Nociceptin; Ventrolateral periaqueductal gray

Indexed keywords

BETA FUNALTREXAMINE; BINALTORPHIMINE; NALTREXONE; NALTRINDOLE; NOCICEPTIN; OPIATE ANTAGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE;

AMYGDALOID NUCLEUS; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; MALE; NEUROMODULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

EID: 0038302041     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)02887-7     Document Type: Article

References (67)

1. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7:1984;309-338.
2. Beitz A.J. The organization of afferent projections to the midbrain periaqueductal gray of the rat. Neuroscience. 7:1982;133-159.
3. Bernard J.F., Besson J.M. The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J. Neurophysiol. 63:1990;473-490.
4. Bjorklund A., Hokfelt T. Handbook of Psychopharmacology. 1984;Elsevier, New York.
5. Borszcz G.C., Streltsov N.G. Amygdaloid-thalamic interactions mediate the antinociceptive action of morphine microinjected into the periaqueductal gray. Behav. Neurosci. 114:2000;574-584.
6. Borszcz G.S. Differential contributions of medullary, thalamic and amygdaloid serotonin to the antinociceptive action of morphine administered into the periquesductal gray: a model of morphine analgesia. Behav. Neurosci. 113:1999;612-631.
7. Burstein R., Potrebic S. Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat. J. Comp. Neurol. 335:1993;469-485.
8. Da Costa Gomez T.M., Chandler S.D., Behbehani M.M. The role of the basolateral nucleus of the amygdala in the pathway between the amygdala and the midbrain periaqueductal gray in the rat. Neurosci. Lett. 114:1996;5-8.
9. Dahlsrom A., Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies on brain stem neurons. Acta Physiol. Scand. 62:(Suppl.):1965;232.
10. J. de Olmos, G.F. Alheid, C. Beltramino, Amygdala, The rat nervous system I. Forebrain and midbrain, G. Paxinos, Academic Press, New York, 1985.
11. Fields H., Basbaum A.I. Brain control of spinal pain transmission neurons. Annu. Rev. Physiol. 40:1978;217-248.
12. Gear R.W., Aley K.O., Levine J.D. Pain-induced analgesia mediated by mesolimbic reward circuits. J. Neurosci. 19:(16):1999;7175-7181.
13. Helmstetter F.J., Bellgowan P.S.F., Poore L.H. Microinfusions of mu, but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail-flick reflex in pentobarbital-anesthetized rats. J. Pharmacol. Exp. Ther. 275:1995;381-388.
14. Helmstetter F.J., Bellgowan P.S., Tershner S.A. Inhibition of the tail-flick reflex following microinjection of morphine into the amygdala. Neuroreport. 4:1993;471-474.
15. Helmstetter F.J., Tershner S.A., Poore L.H., Bellgowan P.S.F. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res. 779:1998;104-108.
16. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
17. Jasmin L., Burkey A.R., Card J.P., Basbaum A.I. Transneuronal labeling of a nociceptive pathway, the spino-(trigemino-)parabrachio-amygdaloid, in the rat. J. Neurosci. 17:1997;3751-3765.
18. Kiefel J.M., Cooper M.L., Bodnar R.J. Inhibition of mesencephalic morphine analgesia by methysergide in the medial ventral medulla of rats. Physiol. Behav. 51:1992;201-205.
19. Kiefel J.M., Cooper M.L., Bodnar R.J. Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia. Brain Res. 597:1992;331-338.
20. Kiefel J.M., Rossi G.C., Bodnar R.J. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624:1993;151-160.
21. King M.A., Rossi G.C., Chang A.H., Williams L., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223:1997;113-116.
22. Kolesnikov Y.A., Pasternak G.W. Peripheral orphanin FQ/nociceptin analgesia in the mouse. Life Sci. 64:1999;2021-2028.
23. Krettak J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 178:1978;225-254.
24. Krettak J.E., Price J.L. A description of the amygdaloid complex in the rat and cat with observations on intra-amygdaloid axonal connections. J. Comp. Neurol. 178:1978;255-280.
25. Letchworth S.R., Mathis J.P., Rossi G.C., Bodnar R.J., Pasternak G.W. Autoradiographic localization of 125-I[Tyr14]Orphanin FQ/Nociceptin and 125-I[Tyr10]Orphanin FQ/Nociceptin1-11 binding sites in rat brain. J. Comp. Neurol. 423:2000;319-329.
26. Ma Q.-P., Shi Y.-S., Han J.-S. Further studies on interactions between periaqueductal gray, nucleus accumbens and habenula in antinociception. Brain Res. 583:1992;292-295.
27. Ma W., Peschanski M. Spinal and trigeminal projections to the parabrachial nucleus in the rat: electron-microscopic evidence of a spino-ponto-amygdalian somatosensory pathway. Somatosens. Res. 5:1998;247-257.
28. Mansour A., Burke S., Pavlic R.J., Akil H., Watson S.J. Immunohistochemical localization of the cloned kappa-1 receptor in the rat CNS. Neuroscience. 71:1996;671-690.
29. Mansour A., Fox C.A., Burke S., Akil H., Watson S.J. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8:1995;283-305.
30. Mansour A., Fox C.A., Burke S., Watson S.J. Immunohistochemical localization of the mu opioid receptors. Regul. Pept. 54:1994;179-180.
31. Mansour A., Fox C.A., Menf F., Akil H., Watson S.J. Kappa-1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol. Cell. Neurosci. 5:1994;124-144.
32. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL-1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
33. Meunier J.C. The potential therapeutic value of nociceptin receptor agonists and antagonists. Exp. Opin. Ther. Patents. 10:2000;371-388.
34. Meunier J.C., Mollereau C., Toll L., Suadeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazargull H., Vassart G., Parmentier M., Constentin J. Isolation and structure of the endogenous agonist of the opioid receptor like ORL1 receptor. Nature. 377:1995;532-535.
35. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., Meunnier J.C. ORL-1, a novel member of the opioid family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
36. Oliveira M.A., Prado W.A. Role of PAG in the antinociception eviked from the medial or central amygdala in rats. Brain Res. Bull. 54:2001;55-63.
37. Pan Y.X., Cheng J., Pasternak G.W. Isolation and characterization of a kappa3 related opioid receptor. Regul. Pept. 54:1994;217-218.
38. Pan Y.X., Cheng J., Xu J., Rossi G., Jacobson E., Ryan-Moro J., Brooks A.I., Dean G.E., Standifer K.M., Pasternak G.W. Cloning and functional characterization through antisense mapping of a kappa3-related opioid receptor. Mol. Pharmacol. 47:1995;1180-1188.
39. Pavlovic Z.W., Bodnar R.J. Opioid supraspinal analgesic synergy between the amygdala and periaqueductal gray in rats. Brain Res. 779:1998;158-169.
40. Pavlovic Z.W., Bodnar R.J. U50488H-induced analgesia in the amygdala: test-specific effects and blockade by opioid antagonists in the periaqueductal gray. Analgesia. 3:1998;223-230.
41. Pavlovic Z., Cooper M.L., Bodnar R.J. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats. Brain Res. 741:1996;13-26.
42. Portoghese P.S., Larson D.L., Sayre L.M., Fries D.S., Takemori A.E. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J. Med. Chem. 23:1980;233-234.
43. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphamine and nor-binaltorphamine, potent and selective K-opioid receptor antagonists. Life Sci. 40:1987;1287-1292.
44. Portoghese P.S., Sultana M., Takemori A.E. Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146:1988;185-186.
45. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civilli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
46. Rizvy T.A., Ennis M., Behbehani M.M., Shipley M.T. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J. Comp. Neurol. 303:1991;121-131.
47. Rodgers R.J. Elevation of aversive threshold in rats by intra-amygdaloid injection of morphine sulphate. Pharmacol. Biochem. Behav. 6:1977;385-390.
48. Rodgers R.J. Influence of intra-amygdaloid opiate injections on shock thresholds, tail-flick latencies and open field behaviour in rats. Brain Res. 153:1978;211-216.
49. Rossi G.C., Leventhal L., Bolan E., Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J. Pharmacol. Exp. Ther. 282:1997;858-865.
50. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone-sensitive orphanin FQ-induced analgesia in mice. Eur. J. Pharmacol. 311:1996;R7-R8.
51. Rossi G.C., Pasternak G.W., Bodnar R.J. Synergistic brainstem interactions for morphine analgesia. Brain Res. 624:1993;171-180.
52. Rossi G.C., Pasternak G.W., Bodnar R.J. Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res. 665:1994;85-93.
53. Rossi G.C., Pellegrino M., Shane R., Abbadie C.A., Dustman J., Jimenez C., Bodnar R.J., Pasternak G.W., Allen R.G. Characterization of rat prepro-orphanin FQ/nociceptin(154-181): nociceptive processing in supraspinal sites. J. Pharmacol. Exp. Ther. 300:2002;257-264.
54. Rossi G.C., Perlmutter M., Leventhal L., Talatti A., Pasternak G.W. Orphainin FQ/nociceptin analgesia in the rat. Brain Res. 792:1998;327-330.
55. Sawynok J., Pinsky C., LaBella F.S. On the specificity of naloxone as an opiate antagonist. Life Sci. 25:1979;1621-1632.
56. Shane R., Lazar D.A., Rossi G.C., Pasternak G.W., Bodnar R.J. Analgesia elicited by OFQ/nociceptin and its fragments from the amygdala in rats. Brain Res. 907:(1-2):2001;109-116.
57. Shane R.M., Wolkin J., Bodnar R.J. Reduction in OFQ/N 1-17-induced analgesia elicited from the amygdala by pretreatment with mu, kappa and delta opioid antagonists in rats. Analgesia. 6:2002;499-505.
58. Spinella M., Cooper M.L., Bodnar R.J. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats. Pain. 64:1996;545-552.
59. Spinella M., Schaefer L.A., Bodnar R.J. Ventral medullary mediation of mesencephalic morphine analgesia by muscarinic and nicotinic cholinergic receptor antagonists in rats. Analgesia. 3:1997;119-130.
60. Spinella M., Znamensky V., Moroz M., Ragnauth A., Bodnar R.J. Actions of NMDA and cholinergic receptor antagonists in the rostral ventromedial medulla upon beta-endorphin analgesia elicited from the ventrolateral periaqueductal gray. Brain Res. 829:1999;151-159.
61. Tershner S.A., Helmstetter F.J. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray. Brain Res. 865:2000;17-26.
62. Urban M.O., Smith D.J. Role of neurotensin in the nucleus raphe magnus in opioid-induced antinociception from the periaqueductal gray. J. Pharmacol. Exp. Ther. 265:1993;580-586.
63. Urban M.O., Smith D.J. Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla. Neurosci. Lett. 174:1994;21-25.
64. Urban M.O., Smith D.J. Nuclei within the rostral ventromedial medulla mediating morphine antinociception from the periaqueductal gray. Brain Res. 652:1994;9-16.
65. vanPraag H., Frenk H. The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes. Brain Res. 524:1990;101-105.
66. Ward S.J., Portoghese P.S., Takemori A.E. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. J. Pharmacol. Exp. Ther. 220:1982;494-498.
67. Yu L.C., Lu J.T., Huang Y.H., Meuser T., Pietruck C., Gabriel A., Grond S., Pierce-Palmer P. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats. Brain Res. 945:2002;88-96.